A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency-Reference-Cited by-同舟云学术

A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency

Published:2022-05 Issue: Volume:109 Page:11-17
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Kato Hisaya,Maezawa Yoshiro^ORCID,Nishijima Dai,Iwamoto Eisuke,Takeda June,Kanamori Takashi^ORCID,Yamaga Masaya,Mishina Tatsuzo,Takeda Yusuke,Izumi Shintaro,Hino Yutaro,Nishi Hiroyuki,Ishiko Jun^ORCID,Takeuchi Masahiro,Kaneko Hiyori^ORCID,Koshizaka Masaya,Mimura Naoya,Kuzuya Masafumi^ORCID,Sakaida Emiko,Takemoto Minoru,Shiraishi Yuichi,Miyano Satoru,Ogawa Seishi,Iwama Atsushi^ORCID,Sanada Masashi,Yokote Koutaro

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference25 articles.

1. Progeria syndromes and ageing: what is the connection?;Burtner;Nat Rev Mol Cell Biol,2010

2. WRN mutation update: mutation spectrum, patient registries, and translational prospects;Yokote;Hum Mutat,2017

3. Japanese diabetic patients with Werner syndrome exhibit high incidence of cancer;Onishi;Acta Diabetol,2012

4. Werner syndrome: a changing pattern of clinical manifestations in Japan (1917–2008);Goto;Biosci Trends,2013

5. An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data;Shiraishi;Nucleic Acids Res,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytogenetics in the management of hematologic neoplasms with germline predisposition: guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10

2. State of the Art of Pharmacological Activators of p53 in Ocular Malignancies;Cancers;2023-07-12

3. Pediatric myelodysplastic syndrome;Seminars in Diagnostic Pathology;2023-05

4. Renal dysfunction, malignant neoplasms, atherosclerotic cardiovascular diseases, and sarcopenia as key outcomes observed in a three-year follow-up study using the Werner Syndrome Registry;Aging;2023-05-01

5. Case Report: A novel WRN mutation in Werner syndrome patient with diabetic foot disease and myelodysplastic syndrome;Frontiers in Endocrinology;2022-07-15